Investors Flock to Biotech March 03, 2014 | Press Release
Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release
Idea to IPO - Transitions in Healthcare 2014 January 29, 2014 | Press ReleaseSee all News
Stem Cell Summit LaunchedMarch 23, 2007
San Francisco, CA - March 23, 2007
The Burrill Life Sciences Media Group, the Genetics Policy Institute (GPI), and the Harvard Stem Cell Institute (HSCI) have joined forces to produce an annual global conference on stem cell research and regenerative medicine. The “Stem Cell Summit” is scheduled for October 2-3, 2007 in Boston, MA.
The Summit builds on a highly successful conference inspired by business and academic leaders in 2006 jointly sponsored by the Massachusetts General Hospital Innovation Fund and the HSCI. It brought together leading researchers, patient advocates, biotechnology executives, experts in policy, law and ethics along with key decision-makers to chart the course so that stem cell technologies will receive proper funding, flourish and fulfill the promise for cures. The Summit seeks to extend the reach and impact of that event by partnering with the leader in the life sciences conference field and the leader in stem cell policy debate. The organizers jointly recognize that the complex field of stem cell research requires the interaction of science and education, policy and advocacy, and commercial interests for ultimate success.
“GPI’s partnering with the Burrill Life Sciences Media Group and the Harvard Stem Cell Institute will help energize the entire community by connecting patients with leading researchers and other experts in related fields of policy, law, ethics and commerce and thereby advance our mutual goal to derive treatments and cures sooner rather than later," said Bernard Siegel, founder and executive director of the Genetics Policy Institute.
“This event is unique because patients around the world are worried about the fate of stem cell research and have begun participating in the debate as never before. The promise of stem cell treatment lies not in the halls of politics but in the hearts of people,” said G. Steven Burrill, CEO of Burrill & Company.
Brock Reeve, Executive Director of the Harvard Stem Cell Institute noted that, “the mission of HSCI is to develop therapies for key diseases. So how swiftly can we move from “bench to bedside”? HSCI was established because this is not just a scientific question – we must connect scientific research and clinical practice with the fields of law, philosophy, and policy. This meeting will help bring us closer to that goal,” added Mr. Reeve.
About Burrill Life Sciences Media Group
Burrill Life Sciences Media Group, a joint venture of Burrill & Company and Nielsen Business Media, produces world wide life sciences conferences, Biotech-2007, bio-intelligence reports, and The Journal of Life Sciences, with the California Health Institute. Biotech-2007, an annual book on the “State of the Industry”, has been an important part of the biotech industry’s view of itself over the last 20 years.
About Genetics Policy Institute (GPI)
GPI is the catalyst of the "Pro-Cures Movement," a global coalition of pro-research stakeholders. Through GPI's meetings, publications, press relations, web site, speaker's bureau and teaching initiatives, GPI educates the public, media and key decision-makers on critical issues. GPI analyzes the law and regulations relating to all aspects of regenerative medicine with an eye to removing bottlenecks, while maintaining rigorous ethical oversight.
About Harvard Stem Cell Institute
The Harvard Stem Cell Institute (HSCI) was formed in 2004 with the mission of fulfilling the promise of stem cell biology to develop therapies for a wide range of chronic medical conditions. HSCI is comprised of the eight schools of Harvard University and its eleven affiliated hospitals and research institutions incorporating over 100 faculty. In addition to scientific and clinical research, HSCI has specific programs in ethics and public policy and public education.
For more information please visit: www.hsci.harvard.edu or call 617-496-4050.
About Burrill & Company
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with principal activities in Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $850 million under management and its merchant banking business is one of the industry leaders in life sciences transactions.
About Nielsen Business Media
Nielsen Business Media is a leading market-focused provider of integrated information, and sales and marketing solutions, helping businesses go to market more effectively and efficiently. Serving six major markets, spanning the entertainment, media and marketing, retail, travel and performance, and design industries, Nielsen Business Media provides business-to-business products and services in print, online and in person.
With 42 publications, over 60 trade shows and 185 digital products and services, Business Media offers insight, analysis and face-to-face contacts to help professionals better understand their markets, serve and sell their customers and grow their businesses.
About The Nielsen Company
The Nielsen Company is a global information and media company with leading market positions and recognized brands in marketing information (ACNielsen), media information (Nielsen Media Research), business publications (Billboard, The Hollywood Reporter, Adweek), trade shows and the newspaper sector (Scarborough Research). The privately held company has more than 42,000 employees and is active in more than 100 countries, with headquarters in Haarlem, the Netherlands, and New York, USA. For more information, please visit, www.nielsen.com.
For Burrill Life Sciences Media Group
Lori Rosen, 212-255-8455
Genetics Policy Institute
Bernard Siegel, 305-801-4928